Talis Biomedical Corporation Stock Split Ratio
Talis Biomedical Corporation reported Stock Split Ratio of 69.90% for the 1-month period ending 2021-02-28, per its 10-Q filed 2021-11-16.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2021-11-16
- 2021-02-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 69.90%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|
| 2021-02-28 | 69.90% 10-Q · filed 2021-11-16 |